Manufacturing technologies and their part to achieve future pharmaceutical sales.pdf

Version 1
Visibility: Open to anyone

    Abstract Global pharma revenue is expected to reach around $1.1-1.3 trillion dollars in the next few years. Even

    with increasing global effluence affordability remains an issue. High priced drugs can deliver the revenue

    but very few can afford them even in mutually subsidized systems.

    Demand dictates API manufacturing process and formulation technologies. Pharmaceutical companies have to take the lead

    through use of best technologies to make drugs affordable to larger population. Unless industry takes the lead billions will be spent by

    very limited patient base.

    Pharma has to internalize technology innovation and wider use of drugs. At current pricing strategies less than 1% of the global

    population will benefit from new the drugs. Regulatory bodies cannot force change and unless pharma takes the lead it will be stuck

    in “analysis paralysis’ mode.